Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 2942.0
(-0.71%)
JPY 2942.0
(-0.71%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 158.8 Billion JPY | -0.02% |
| 2022 | 158.83 Billion JPY | -2.64% |
| 2021 | 163.13 Billion JPY | 0.83% |
| 2020 | 161.79 Billion JPY | 2.73% |
| 2019 | 157.48 Billion JPY | -0.96% |
| 2018 | 159.01 Billion JPY | 2.56% |
| 2017 | 155.05 Billion JPY | 4.5% |
| 2016 | 148.37 Billion JPY | 7.74% |
| 2015 | 137.71 Billion JPY | 7.96% |
| 2014 | 127.55 Billion JPY | -2.38% |
| 2013 | 130.66 Billion JPY | 8.14% |
| 2012 | 120.82 Billion JPY | 7.05% |
| 2011 | 112.87 Billion JPY | 3.95% |
| 2010 | 108.57 Billion JPY | 1.62% |
| 2009 | 106.84 Billion JPY | 4.4% |
| 2008 | 102.34 Billion JPY | -1.14% |
| 2007 | 103.52 Billion JPY | -5.63% |
| 2006 | 109.7 Billion JPY | 3.26% |
| 2005 | 106.24 Billion JPY | 1.31% |
| 2004 | 104.87 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 158.43 Billion JPY | 0.24% |
| 2024 Q1 | 158.05 Billion JPY | -0.47% |
| 2023 Q2 | 156.4 Billion JPY | -0.63% |
| 2023 Q3 | 157.82 Billion JPY | 0.91% |
| 2023 Q1 | 157.39 Billion JPY | -0.9% |
| 2023 FY | 158.8 Billion JPY | -0.02% |
| 2023 Q4 | 158.8 Billion JPY | 0.62% |
| 2022 Q2 | 160.24 Billion JPY | -1.3% |
| 2022 Q3 | 160.22 Billion JPY | -0.01% |
| 2022 Q4 | 158.83 Billion JPY | -0.87% |
| 2022 FY | 158.83 Billion JPY | -2.64% |
| 2022 Q1 | 162.35 Billion JPY | -0.48% |
| 2021 Q2 | 162.35 Billion JPY | 0.07% |
| 2021 Q3 | 164.99 Billion JPY | 1.62% |
| 2021 Q4 | 163.13 Billion JPY | -1.12% |
| 2021 FY | 163.13 Billion JPY | 0.83% |
| 2021 Q1 | 162.24 Billion JPY | 0.28% |
| 2020 Q4 | 161.79 Billion JPY | 0.75% |
| 2020 Q3 | 160.58 Billion JPY | 1.33% |
| 2020 FY | 161.79 Billion JPY | 2.73% |
| 2020 Q2 | 158.48 Billion JPY | 0.92% |
| 2020 Q1 | 157.03 Billion JPY | -0.29% |
| 2019 Q3 | 157.4 Billion JPY | 1.76% |
| 2019 FY | 157.48 Billion JPY | -0.96% |
| 2019 Q2 | 154.69 Billion JPY | -1.41% |
| 2019 Q1 | 156.9 Billion JPY | -1.33% |
| 2019 Q4 | 157.48 Billion JPY | 0.05% |
| 2018 FY | 159.01 Billion JPY | 2.56% |
| 2018 Q3 | 157.78 Billion JPY | -1.34% |
| 2018 Q2 | 159.92 Billion JPY | 0.29% |
| 2018 Q1 | 159.45 Billion JPY | 2.84% |
| 2018 Q4 | 159.01 Billion JPY | 0.79% |
| 2017 FY | 155.05 Billion JPY | 4.5% |
| 2017 Q4 | 155.05 Billion JPY | 1.32% |
| 2017 Q3 | 153.03 Billion JPY | -0.55% |
| 2017 Q2 | 153.88 Billion JPY | 2.06% |
| 2017 Q1 | 150.78 Billion JPY | 1.63% |
| 2016 Q2 | 138.03 Billion JPY | -0.9% |
| 2016 Q3 | 144.69 Billion JPY | 4.82% |
| 2016 Q1 | 139.29 Billion JPY | 1.15% |
| 2016 Q4 | 148.37 Billion JPY | 2.54% |
| 2016 FY | 148.37 Billion JPY | 7.74% |
| 2015 Q2 | 129.45 Billion JPY | -0.81% |
| 2015 FY | 137.71 Billion JPY | 7.96% |
| 2015 Q4 | 137.71 Billion JPY | -0.29% |
| 2015 Q3 | 138.11 Billion JPY | 6.69% |
| 2015 Q1 | 130.51 Billion JPY | 2.32% |
| 2014 Q3 | 127.02 Billion JPY | 0.47% |
| 2014 Q2 | 126.43 Billion JPY | -0.09% |
| 2014 FY | 127.55 Billion JPY | -2.38% |
| 2014 Q1 | 126.55 Billion JPY | -3.15% |
| 2014 Q4 | 127.55 Billion JPY | 0.42% |
| 2013 Q2 | 120.72 Billion JPY | -1.02% |
| 2013 Q4 | 130.66 Billion JPY | 3.67% |
| 2013 FY | 130.66 Billion JPY | 8.14% |
| 2013 Q1 | 121.96 Billion JPY | 0.94% |
| 2013 Q3 | 126.04 Billion JPY | 4.41% |
| 2012 FY | 120.82 Billion JPY | 7.05% |
| 2012 Q2 | 115.82 Billion JPY | 1.89% |
| 2012 Q3 | 116.1 Billion JPY | 0.25% |
| 2012 Q4 | 120.82 Billion JPY | 4.06% |
| 2012 Q1 | 113.67 Billion JPY | 0.71% |
| 2011 FY | 112.87 Billion JPY | 3.95% |
| 2011 Q3 | 114.72 Billion JPY | -2.17% |
| 2011 Q2 | 117.27 Billion JPY | 3.28% |
| 2011 Q4 | 112.87 Billion JPY | -1.62% |
| 2011 Q1 | 113.54 Billion JPY | 4.57% |
| 2010 Q2 | 108.82 Billion JPY | 1.7% |
| 2010 Q1 | 107 Billion JPY | 0.15% |
| 2010 Q3 | 110.12 Billion JPY | 1.19% |
| 2010 FY | 108.57 Billion JPY | 1.62% |
| 2010 Q4 | 108.57 Billion JPY | -1.4% |
| 2009 Q3 | 108.18 Billion JPY | 2.73% |
| 2009 Q4 | 106.84 Billion JPY | -1.23% |
| 2009 FY | 106.84 Billion JPY | 4.4% |
| 2009 Q2 | 105.3 Billion JPY | 0.0% |
| 2008 Q4 | 102.34 Billion JPY | 0.0% |
| 2008 FY | 102.34 Billion JPY | -1.14% |
| 2007 FY | 103.52 Billion JPY | -5.63% |
| 2006 FY | 109.7 Billion JPY | 3.26% |
| 2005 FY | 106.24 Billion JPY | 1.31% |
| 2004 FY | 104.87 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -334.2% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 98.949% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 82.501% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 88.793% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -929.761% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 39.712% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 7.472% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 88.607% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -824.169% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 51.7% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -107.69% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -220.497% |
| Tsumura & Co. | 428.25 Billion JPY | 62.919% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 39.141% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -19.012% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 63.126% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -86.097% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -5.491% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | 10.625% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -955.43% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -104.355% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -934.39% |
| MedRx Co., Ltd | 2.05 Billion JPY | -7638.791% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -738.069% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -6127.451% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -7738.395% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -70.182% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 58.432% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -3667.668% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 79.468% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -396.188% |